Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005550602
Thu, 25.04.2024
Drägerwerk AG & Co. KGaA
Dräger with solid business performance in the first quarter of 2024
Order intake slightly above high prior-year level
Net sales and earnings below strong prior-year quarter due to base effects
Annual forecast confirmed
Lübeck – Drägerwerk AG & Co. KGaA increased its order intake in the first quarter of 2024 thanks to good overall demand. At [ … ]
Thu, 07.03.2024
Drägerwerk AG & Co. KGaA
Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend
Order intake (net of currency effects) slightly above the high prior-year level
Net sales increase by around 13 percent (net of currency effects) compared to the prior year
Both divisions and all regions contribute to net sales growth
[ … ]
Mon, 15.01.2024
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures 2023: Net sales and earnings significantly above prior year – Dividend increase – Forecast 2024
Lübeck, January 15, 2024 – Dräger's net sales and earnings increased significantly in fiscal year 2023 based on preliminary calculations. This w [ … ]
Wed, 13.12.2023
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Annual forecast raised again
Lübeck, December 13, 2023 – Dräger's net sales and earnings in the current fourth quarter of 2023 have so far exceeded the Company’s expectations. This is due to continued high net sales recognition with high-margin products and ef [ … ]
Wed, 13.12.2023
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Annual forecast raised again
Lübeck, December 13, 2023 – Dräger's net sales and earnings in the current fourth quarter of 2023 have so far exceeded the Company’s expectations. This is due to continued high net sales recognition with high-margin products and ef [ … ]
Mon, 20.11.2023
Drägerwerk AG & Co. KGaA
Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052: Purchase of own shares – final notice
In the period from 4 October 2023 to 17 November 2023 (inclusive), a total of 80,460 preferred shares were bought back within the framework of the share buyback of D [ … ]
Thu, 02.11.2023
Drägerwerk AG & Co. KGaA
Dräger significantly increases net sales and earnings in the first nine months of 2023
Order intake (net of currency effects) slightly above the high prior-year level
Net sales increase by around 17 percent (net of currency effects) compared to the prior-year period
Both divisions and all regions contribute to net sales growth
Noticeable improv [ … ]
Mon, 16.10.2023
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings – full-year forecast raised
Lübeck, October 16, 2023 – Dräger's net sales and earnings increased significantly in the third quarter of 2023 based on preliminary calculations. This was due in particu [ … ]
Mon, 02.10.2023
Drägerwerk AG & Co. KGaA
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
On September 11, 2023, the Executive Board of Drägerwerk Verwaltungs AG resolved an employee participation program for Drägerwerk AG & Co. KGaA (“Dräger”). For this purpose, Dräger will buy back som [ … ]
Thu, 27.07.2023
Drägerwerk AG & Co. KGaA
Dräger with significant increase in net sales and earnings in the first half of 2023
Net sales increase of around 20 percent compared to the prior-year period
Noticeable improvement in delivery capabilities
Net sales growth across both segments and all regions
EBIT well up at around EUR 48 million
Order intake slightly below high prior-year le [ … ]